Stemina Biomarker Discovery, Inc. - Pharmaceuticals & Healthcare

1
Stemina Biomarker Discovery, Inc. -
Pharmaceuticals Healthcare
One-Stop Shop for Business Information
2
Summary
Stemina Biomarker Discovery, Inc. (SBDI) is a
metabolomics company. The company discovers,
develops and commercializes molecular biomarkers
for the improvement of human health and drug
safety. It analyzes the small molecules secreted
by human embryonic stem (hES) cells such as,
heart and neural cells made from hES cells and
pluripotent stem cells in response to drugs,
injury or disease. SBDIs technologies include
biomarker discovery, validation, predictive
toxicology and biological pathway analysis. The
company works on research projects and joint
development agreements with partners to develop
drugs. It partners with ILS and the CiToxLAB
Group. SBDI is headquartered in Madison,
Wisconsin, the US. Stemina Biomarker Discovery,
Inc. - Pharmaceuticals Healthcare - Deals and
Alliances Profile provides you comprehensive data
and trend analysis of the company's Mergers and
Acquisitions (MAs), partnerships and
financings. 
3

•  The report provides detailed information on
  Mergers and Acquisitions, Equity/Debt Offerings,
  Private Equity, Venture Financing and Partnership
  transactions recorded by the company over a five
  year period. The report offers detailed
  comparative data on the number of deals and their
  value categorized into deal types, sub-sector and
  regions.
• GlobalData derived the data presented in this
  report from proprietary in-house Pharma eTrack
  deals database, and primary and secondary
  research.
• Scope
• Financial Deals - Analysis of the company's
  financial deals including Mergers and
  Acquisitions, Equity/Debt Offerings, Private
  Equity, Venture Financing and Partnerships.

4

• - Deals by Year - Chart and table displaying
  information encompassing the number of deals and
  value reported by the company by year, for a five
  year period.
• Deals by Type - Chart and table depicting
  information including the number of deals and
  value reported by the company by type such as
  Mergers and Acquisitions, Equity/Debt Offering
  etc.
• - Deals by Region - Chart and table presenting
  information on the number of deals and value
  reported by the company by region, which includes
  North America, Europe, Asia Pacific, the Middle
  East and Africa and South and Central America.
• Deals by Sub-sector - Chart and table showing
  information on the number of deals and value
  reported by the company, by sub-sector.

5

• Major Deals - Information on the company's major
  financial deals. Each such deal has a brief
  summary, deal type, deal rationale and deal
  financials and target Companys (major public
  companies) key financial metrics and ratios.
• - Business Description - A brief description of
  the company's operations.- Key Employees - A
  list of the key executives of the company.-
  Important Locations and Subsidiaries - A list and
  contact details of key centers of operation and
  subsidiaries of the company.- Key Competitors -
  A list of the key competitors of the company.-
  Key Recent Developments - A brief on recent news
  about the company.

6
Table Of Content

• List of Figures 3Stemina Biomarker Discovery,
  Inc., Pharmaceuticals Healthcare, Deals By
  Year, 2008 to YTD 2014 4Stemina Biomarker
  Discovery, Inc., Pharmaceuticals Healthcare
  Deals By Type, 2008 to YTD 2014 5
• List of TablesStemina Biomarker Discovery, Inc.,
  Pharmaceuticals Healthcare, Key Facts 1Stemina
  Biomarker Discovery, Inc., Pharmaceuticals
  Healthcare, Deals By Year, 2008 to YTD 2014 1
• List of FiguresStemina Biomarker Discovery,
  Inc., Pharmaceuticals Healthcare, Deals by
  Type, 2008 to YTD 2014 1Stemina Biomarker
  Discovery, Inc., Pharmaceuticals Healthcare,
  Deals By Year, 2008 to YTD 2014 4

7

• To know more
• Stemina Biomarker Discovery, Inc. -
  Pharmaceuticals Healthcare

Contact Us-Call India 91-22-27810772/73 Call
USA/Canada (Toll Free) 1-866-279-8368 Email id
info_at_bharatbook.com